AXA Investment Managers UK Ltd

Fund Company

AXA Investment Managers UK Ltd - http://www.axa-im.co.uk/
 

AXA IM's performance in 2011 confirms the soundness of their multi-expert asset management model which has yet again proved resilient in an extremely challenging environment for the industry. The investment performance generated for clients has continued to improve and demonstrates the value of their active management approach in difficult market conditions.


The much enhanced profitability of AXA IM in 2011 exceeding pre-crisis levels, has confirmed the success of their past efforts to reinforce and fine tune their multi-expert model. The agility and innovation of independent investment teams combined with the scale of one of the largest global and diversified asset managers in the world, has enabled AXA IM to retain and win new clients in a testing and uncertain environment.


Although 2012 will continue to be challenging for the financial sector, as a long term investor dedicated to active management, AXA IM is ideally placed to capture the opportunities presented to investors by evolving markets. AXA IM will continue to foster partnerships based on trust and transparency with their clients and capitalise on their solutions approach to address the ever growing and complex investment needs of clients globally.

Company

Fund Name

ISIN

Currency

Inception Date

Rating

Risk

Profile

AXA Investment Managers UK Ltd.

AXA Framlington UK Sel Opp GBP Cap

GB0003501581

GBP

13/01/1969

5

Medium

The fund aims to achieve capital growth by investing in companies, primarily of UK origin where the Manager believes above average returns can be realised.

AXA Investment Managers UK Ltd.

AXA Framlington Managed Bal Cap

GB0003509659

GBP

31/12/1992

5

High

The Fund aims to achieve capital growth through investment in a broad range of securities in all or any economic sectors in all or any parts of the world which, in the Managers opinion show above-average profitability, management quality and growth, balancing risk and return for investors.

AXA Investment Managers UK Ltd.

AXA Framlington Biotech R GBP Cap

GB0031007254

GBP

27/11/2001

3

Medium

To provide long-term capital appreciation by investing principally in equity securities of companies in biotechnology, genomic and medical research industries worldwide.